The judge in an Arkansas case against Johnson & Johnson (JNJ -0.5%) tags the firm with a $1.1B...

|About: Johnson & Johnson (JNJ)|By:, SA News Editor

The judge in an Arkansas case against Johnson & Johnson (JNJ -0.5%) tags the firm with a $1.1B penalty after it was found guilty of deception over the marketing of antipyschotic drug Risperdal. Shares of JNJ are snoozing the news with the verdict and obligatory appeal already anticipated.